台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    80.5
  • 漲跌
    ▲4.2
  • 漲幅
    +5.50%
  • 成交量
    821
  • 產業
    上櫃 生技醫療類股
  • 524人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
台康生技 (6589)籌碼相關-凱基-雙和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-雙和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.00078.6580.5001,2370.00%
2025/01/1700.00080.8081.2001,2500.00%
2025/01/1500.00078.8079.0001,2410.00%
2025/01/1400.00078.4078.3001,2360.00%
2025/01/1300.00077.9077.9001,2290.00%
2025/01/1000.00077.4777.9001,2220.00%
2025/01/0900.00075.4075.8001,2030.00%
2025/01/0800.00074.7074.9001,1900.00%
2024/12/2700.000.271.8070.90-0.21,164-0.02%
2024/12/130.268.100.271.2068.0001,1860.00%
2024/12/1200.00274.1073.50-21,110-0.18%
2024/12/111.177.8500.0076.601.11,0450.11%
2024/12/100.182.9000.0082.900.19450.01%
2024/12/0900.00092.5092.1009320.00%
2024/12/0500.00791.8491.50-7902-0.78%
2024/12/04192.1000.0092.3018990.11%
2024/11/29195.00693.7094.20-5845-0.59%
2024/11/27892.98092.7091.1087971.00%
2024/11/260.188.3000.0089.000.17490.01%
2024/11/2000.00786.5087.40-7738-0.95%
2024/11/05793.04094.4094.1076911.01%
2024/11/0100.00094.1091.8006800.00%
2024/10/3000.00093.5093.0006580.00%
2024/10/2900.00092.4091.6006350.00%
2024/10/25089.1000.0089.1005940.00%
2024/10/2400.00090.9090.9005940.00%
2024/09/24194.1000.0091.5019370.11%
2024/09/2300.00092.0094.0009370.00%
2024/09/2000.00089.8089.3009700.00%
2024/09/1800.00088.8088.8009620.00%
2024/08/0100.00088.7089.0001,1690.00%
2024/07/1800.00094.6093.4001,1180.00%
2024/07/1700.00094.3594.3001,1010.00%
2024/07/0800.00095.0093.4001,0660.00%
2024/07/0500.00293.3093.00-21,054-0.19%
2024/07/02198.20199.5097.1009910.00%
2024/07/01293.90393.0096.50-1891-0.11%
2024/06/26491.1800.0090.6047560.53%
2024/06/120.486.2000.0084.500.46220.06%
2024/06/11486.30486.0586.3005420.00%
2024/05/2700.00179.4079.50-1541-0.18%
2024/05/1400.00180.3082.30-1563-0.18%
2024/03/11388.9000.0088.6036460.46%
2024/02/2000.00295.0095.00-2879-0.23%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-2024/12/14
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音